2022 Partners
Exelead
Lead Partner
Scientists are driven by powerful ideas to develop innovative molecules that can save lives, But to bring their drug to market, they must navigate pharmaceutical manufacturing, clinical trials, logistical complexities and strict regulations. Exelead guides you through each step, so you can get your drug to patients that need it.
Exelead specializes in manufacturing lipid nanoparticle, liposomal, and pegylated formulations. We work with you to bring your drug from development to commercialization.
Exelead has been acquired by MilliporeSigma, the Life Science business of Merck KGaA, Darmstadt, Germany.
Precision NanoSystems
Expertise Partner
PNI is a global leader in ushering in the next wave of genetic medicines in infectious diseases, cancer, and rare diseases. We work with the world’s leading drug developers to understand disease and create the therapeutics and vaccines that will define the future of medicine. PNI offers proprietary technology platforms and comprehensive expertise to enable researchers to translate disease biology insights into non-viral genetic medicines.
Arranta Bio
Expertise Partner
Arranta Bio is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialize therapies targeting the human microbiome. With a ten-year legacy as Captozyme, Arranta’s has a proven track record with 125 species in process development and contract manufacturing of live biopharmaceuticals, and provides the resources necessary to help clients to deliver promising new microbiome therapies to meet the needs of patients.
AexeRNA
Expertise Partner
aexeRNA Therapeutics is developing mRNA therapeutics utilizing its proprietary next generation programmable and highly potent Lipid Nanoparticle (LNP) nucleic acid delivery system. The aexLNP system was developed at George Mason University and the University of Pennsylvania.
Wyatt Technology
Expertise Partner
Wyatt Technology is the recognized leader in instrumentation and software for determining the absolute molar mass, size, charge and interactions of macromolecules and nanoparticles in solution. These tools include: in-line multi-angle static light scattering – SEC-MALS, high-throughput dynamic light scattering – DLS, high-sensitivity electrophoretic mobility – MP-PALS, field flow fractionation – FFF-MALS, automated composition gradients for interaction analysis – CG-MALS, differential refractometry, and differential viscosity. Wyatt's training, service and support are widely considered the industry benchmark of excellence.
Particle Works
Hosting Partner
Providing innovative platforms for particle production used to advance medicines & therapeutics. A new company spun out of Dolomite Microfluidics building on 20 years’ experience of creating cutting-edge products - we pave the way for particle perfection. Our innovative particle technology enables you to formulate faster, be ready for your next breakthrough, and scale up your discoveries. Join us in April 2022 to unlock the true power of particles.
Micropore Technologies
Panel Partner
Designed using QbD principles, Micropore offers a seamlessly scalable LNP manufacturing solution from around 50 micrograms for initial product characterization, all the way up to 1,000 Litres/hour for full scale production. Zero mRNA degradation is a key attribute of this low-pressure process.
Using a single geometry, the combination of tunable size, size distribution together with PAT integration assures our clients that anything they develop at the smallest scale can be transferred into manufacturing at speed and with ease. Micropore is sufficiently confident in its solution that it offers process guarantees.
eTheRNA
Innovation Partner
eTheRNA is an mRNA technology discovery and development company with a full platform of integrated capabilities including: mRNA construct design and optimization; proprietary lipid nanoparticle (LNP) formulations which have demonstrated organ-specific distribution preclinically; process development and manufacturing capabilities for mRNA drug substance (gram GMP scale); and proprietary LNP / final product formulation technologies, including a lyophilized thermostable formulation in advanced development. With a focus on immune modulation and T Cell stimulation, eTheRNA is pursuing internal development programs to validate its core technologies and enable strategic partnerships in a range of geographic markets and therapeutic areas. eTheRNA is backed by a global syndicate of leading investors and is headquartered in Belgium with offices in New York and Hong Kong.
NanoFCM
Innovation Partner
NanoFCM designs advanced analytical instrumentation allowing the measurement of biological and synthetic substrates, such as lipid nanoparticles, extracellular vesicles and viruses. The NanoAnalyzer platform offers a flexible, high throughput solution to for the single-particle, multiparameter characterisation of novel nano-sized therapeutics using nano-flow cytometry. By measuring simultaneously physical size, concentration and therapeutic content, the NanoAnalyzer can assess the encapsulation rate of API in individual nanoparticles, speeding-up development, approval and quality control of novel drugs and vaccines.
Advanced Instruments
Exhibition Partner
Advanced Instruments is a global company offering a novel portfolio of analytical tools including, OsmoTECH®, a robust line of micro-osmometers to support bioprocessing and quality control (QC), and Solentim®, a portfolio of best in class imaging and single-cell deposition technologies for cell line development workflows and assurance of clonality for regulatory bodies. Advanced Instruments helps drive fast, consistent and reliable decision making throughout bioprocessing workflows empowering the development & manufacture of biotherapeutics.
Cayman Chemical
Exhibition Partner
Partner with Cayman and utilize 42 years’ experience in synthesis, purification, and characterization of lipids. Cayman manufactures an expansive selection of high-purity lipids utilized in LNP and liposome development including commercial and custom phospholipids, cationic and, anionic lipids. Our client-focused services include custom synthesis, purification, characterization, and custom API manufacturing. We couple your vision with our expertise to match your payload with the world’s best lipids and lipid chemists.
Lipoid
Exhibition Partner
Since its foundation in 1977, Lipoid has gained an outstanding reputation in the development and industrial production of high-quality lecithin, phospholipids, and other lipid products, meeting the high standards of the pharmaceutical industry. Lipoid is the world’s leading company for the production and supply of a wide range of natural and synthetic phospholipid excipients on an industrial scale.
Ardena
Exhibition Partner
Ardena is a pharmaceutical CDMO that guides companies through the drug discovery and development process to help create effective and compliant drug substance and products for clinical trials. Ardena provides you with an integrated service offering including solid state chemistry, API & nanomedicines development and manufacturing, analytical & formulation development, drug product manufacturing, bioanalytical, drug discovery and dossier development services.
KNAUER
Exhibition Partner
KNAUER are a berlin-based manufacturer of high-tech scientific instruments, whose strength lies in liquid engineering.
KNAUER manufactures systems for the production of lipid nanoparticle-based formulations, such as mRNA vaccines. Their NanoProducer units, which use KNAUER’s Impingement Jets Mixing (IJM) technology, are used worldwide in the high-volume production of mRNA COVID-19 vaccines.
Their latest LNP system, the NanoScaler, is designed specifically for the pre-scale up R&D of new mRNA therapies.
Think LNP. Think KNAUER.
Microfluidics
Exhibition Partner
Microfluidics International Corporation, the manufacturer of Microfluidizer® high- shear fluid processors, is a leader in the design and production of laboratory and commercial processing equipment for nano-scale material.
Microfluidizer® technology is a proven method of achieving superior, solvent-free lipid nanoparticles with controlled particle sizes and narrow distributions.
This unique top-down technology can conform to cGMP regulations.
Microfluidizer® technology is linearly scalable for consistent, repeatable results from research & development to production-scale volumes.